Sphaira Medical raises 2.2 million euros

The Berlin-based start-up has developed a protective capsule designed to give patients in medical isolation more contact with others. This convinces investors.

Medtech Sphaira Medical receives seed financing of 2.2 million euros. Investitionsbank Berlin Brandenburg (IBB) invests with its Early Stage and ProFIT programs. Business angels such as Caroll Neubauer, Florian Meißner and Silke Rickert-Sperling also participated in the financing round.

Since 2020, founder Janis Münch and his team have been working on the development of the Moby mobile protective capsule. Through the capsule, vulnerable or infectious patients could have contact with relatives and medical staff. With the new funding, the start-up wants to push ahead with clinical studies and the approval of the protective capsule, primarily in the EU and the US.

"I hope that the fresh capital for Sphaira Medical will bring us a big step closer to the daily use of Moby for immunocompromised children with cancer, enabling us to increasingly break through the burdensome isolation of our patients," says Angelika Eggert, director of pediatric oncology at Charité Berlin.